Department of Pathology,
Human Oncology and Pathogenesis Program
Michael F Berger has not added Biography.
If you are Michael F Berger and would like to personalize this page please email our Author Liaison for assistance.
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays.
Nature genetics Dec, 2004 | Pubmed ID: 15543148
Protein binding microarrays (PBMs) for rapid, high-throughput characterization of the sequence specificities of DNA binding proteins.
Methods in molecular biology (Clifton, N.J.) , 2006 | Pubmed ID: 16888363
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities.
Nature biotechnology Nov, 2006 | Pubmed ID: 16998473
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae.
Genome research Apr, 2007 | Pubmed ID: 17322287
Inferring condition-specific transcription factor function from DNA binding and gene expression data.
Molecular systems biology , 2007 | Pubmed ID: 17437025
Microarray analyses of newborn mouse ovaries lacking Nobox.
Biology of reproduction Aug, 2007 | Pubmed ID: 17494914
Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences.
Cell Jun, 2008 | Pubmed ID: 18585359
Design of compact, universal DNA microarrays for protein binding microarray experiments.
Journal of computational biology : a journal of computational molecular cell biology Sep, 2008 | Pubmed ID: 18651798
The Vibrio harveyi master quorum-sensing regulator, LuxR, a TetR-type protein is both an activator and a repressor: DNA recognition and binding specificity at target promoters.
Molecular microbiology Oct, 2008 | Pubmed ID: 18681939
Predicting the binding preference of transcription factors to individual DNA k-mers.
Bioinformatics (Oxford, England) Apr, 2009 | Pubmed ID: 19088121
Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.
Cancer research Jan, 2009 | Pubmed ID: 19147588
High-resolution DNA-binding specificity analysis of yeast transcription factors.
Genome research Apr, 2009 | Pubmed ID: 19158363
Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors.
Nature protocols , 2009 | Pubmed ID: 19265799
Diversity and complexity in DNA recognition by transcription factors.
Science (New York, N.Y.) Jun, 2009 | Pubmed ID: 19443739
Applications of genomics in melanoma oncogene discovery.
Hematology/oncology clinics of North America Jun, 2009 | Pubmed ID: 19464593
Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts.
Genome biology , 2009 | Pubmed ID: 19835606
Conservation and regulatory associations of a wide affinity range of mouse transcription factor binding sites.
Genomics Apr, 2010 | Pubmed ID: 20079828
Integrative analysis of the melanoma transcriptome.
Genome research Apr, 2010 | Pubmed ID: 20179022
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo.
The EMBO journal Jul, 2010 | Pubmed ID: 20517297
Objective sequence-based subfamily classifications of mouse homeodomains reflect their in vitro DNA-binding preferences.
Nucleic acids research Dec, 2010 | Pubmed ID: 20705649
Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSL.
PloS one , 2010 | Pubmed ID: 21124806
The genomic complexity of primary human prostate cancer.
Nature Feb, 2011 | Pubmed ID: 21307934
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2011 | Pubmed ID: 21383288
The mutational landscape of head and neck squamous cell carcinoma.
Science (New York, N.Y.) Aug, 2011 | Pubmed ID: 21798893
Molecular mechanism underlying the regulatory specificity of a Drosophila homeodomain protein that specifies myoblast identity.
Development (Cambridge, England) Mar, 2012 | Pubmed ID: 22296846
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature Mar, 2012 | Pubmed ID: 22460905
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
Cancer discovery Jan, 2012 | Pubmed ID: 22585170
Melanoma genome sequencing reveals frequent PREX2 mutations.
Nature May, 2012 | Pubmed ID: 22622578
Genome sequencing identifies a basis for everolimus sensitivity.
Science (New York, N.Y.) Oct, 2012 | Pubmed ID: 22923433
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
Cancer Feb, 2013 | Pubmed ID: 22930283
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2013 | Pubmed ID: 23444215
Punctuated evolution of prostate cancer genomes.
Cell Apr, 2013 | Pubmed ID: 23622249
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved